Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Microb Pathog ; 100: 56-61, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27616446

RESUMO

Chaperone-usher (CU) fimbriae, which are adhesive surface organelles found in many Gram-negative bacteria, mediate tissue tropism through the interaction of fimbrial adhesins with specific receptors expressed on the host cell surface. A CU fimbrial gene yfcO, was identified in avian pathogenic E. coli (APEC) strain DE205B via gene functional analysis. In this study, yfcO was found in 13.41% (11/82) of E. coli strains, including phylogenetic groups A, B1, B2 and D, with the highest percentage in group B2. The expression of yfcO in biofilm forming bacteria was significantly higher (P < 0.05) than that in the planktonic bacteria. A yfcO deletion mutant was constructed, and adherence to DF-1 chicken embryo fibroblast cells was analyzed in vitro. Compared to the wild-type (WT), adherence of the mutant to DF-1 cells was significantly decreased (P < 0.01). The mutant bacterial loads in the heart, brain and liver were significantly lower (P < 0.05) than those of the WT strain. Resistance of the mutant to acidic (acetic, pH 4.0, 20 min) and high osmolarity (2.5 M NaCl, 1 h) stress conditions decreased by 51.28% (P < 0.001) and 80.34% (P < 0.01), respectively. These results suggest that yfcO contributes to APEC virulence through bacterial adherence to host tissues.


Assuntos
Adesinas Bacterianas/metabolismo , Aderência Bacteriana , Proteínas da Membrana Bacteriana Externa/metabolismo , Infecções por Escherichia coli/patologia , Proteínas de Escherichia coli/metabolismo , Escherichia coli/fisiologia , Escherichia coli/patogenicidade , Fímbrias Bacterianas/fisiologia , Adesinas Bacterianas/genética , Estruturas Animais/microbiologia , Animais , Carga Bacteriana , Proteínas da Membrana Bacteriana Externa/genética , Biofilmes/crescimento & desenvolvimento , Linhagem Celular , Galinhas , Modelos Animais de Doenças , Escherichia coli/classificação , Escherichia coli/genética , Infecções por Escherichia coli/microbiologia , Proteínas de Escherichia coli/genética , Fibroblastos/microbiologia , Deleção de Genes , Genótipo , Cloreto de Sódio/metabolismo , Virulência
2.
BMC Vet Res ; 12(1): 167, 2016 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-27531140

RESUMO

BACKGROUND: Avian pathogenic Escherichia coli (APEC) causes avian colibacillosis, which results in economic and welfare costs in the poultry industry worldwide. The pathogenesis of avian pathogenic E. coli strains is not well defined. Here, the function of an outer membrane protein encoded by the ireA gene of avian pathogenic E. coli strain DE205B was investigated. RESULTS: The ireA gene was distributed in 32.9 % (46/140) of tested E. coli strains, with high percentages in the phylogenetic ECOR groups B2 (58.8 %, 10/17) and D (55.9 %, 19/34). The gene expression level of ireA of APEC strain DE205B in high Fe M9 media was 1.8 times higher (P < 0.05) than that in low Fe M9 media. An ireA deletion mutant and complementary strain were constructed. Compared with the wild-type strain DE205B, the expression of most ferric uptake genes in the ireA deletion mutant were significantly upregulated (P < 0.05). The adhesion ability of the ireA deletion mutant to DF-1 cells was significantly decreased. The survival rate of ireA deletion mutant was reduced 21.17 % (P < 0.01), 25.42 (P < 0.05) and 70.0 % (P < 0.01) under alkali, high osmolarity, and low temperature (4 °C) conditions, respectively, compared with the wild-type strain. CONCLUSIONS: The results suggested that the protein encoded by the iron-regulated gene ireA has roles in adhesion and stress resistance in avian pathogenic E. coli.


Assuntos
Aderência Bacteriana/fisiologia , Proteínas de Escherichia coli/metabolismo , Escherichia coli/classificação , Regulação Bacteriana da Expressão Gênica/fisiologia , Doenças das Aves Domésticas/microbiologia , Estresse Fisiológico/fisiologia , Animais , Aderência Bacteriana/genética , Patos , Escherichia coli/genética , Escherichia coli/fisiologia , Proteínas de Escherichia coli/genética , Mutação , Doenças das Aves Domésticas/patologia , Estresse Fisiológico/genética
3.
Appl Environ Microbiol ; 81(21): 7377-84, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26253669

RESUMO

Streptococcus suis and Streptococcus equi subsp. zooepidemicus are capable of infecting humans and various animals, causing significant problems for the worldwide swine industry. As antibiotic resistance has increased, lysosomal enzymes encoded by phages have shown potential for use against pathogenic bacteria. In this study, a novel bacteriophage lysin, Ply30, encoded by the S. suis prophage phi30c, was recombinantly expressed and purified. Ply30 showed high bacteriolysis activity on S. suis and S. equi subsp. zooepidemicus in vitro. The ratio of the optical density at 600 nm (OD600) with treatment versus the OD600 with no treatment for most tested S. suis and S. equi subsp. zooepidemicus strains decreased from 1 to <0.3 and <0.5, respectively, within 1 h. The results of plate viability assays showed that treated bacteria suffered a 1- to 2-log decrease in CFU within 1 h. The optimal concentration of Ply30 was 50 µg/ml, and the optimal pH was 7. Moreover, Ply30 maintained high activity over a wide pH range (pH 6 to 10). The MICs of Ply30 against Streptococcus strains ranged from 16 to 512 µg/ml. In vivo, a 2-mg dose of Ply30 protected 90% (9/10 mice) of mice from infection with S. equi subsp. zooepidemicus and 80% (8/10 mice) of mice from infection with S. suis. Seven days after lysin Ply30 treatment, bacterial loads were significantly decreased in all tested organs and blood compared with those at 1 h postinfection without Ply30 treatment. Ply30 showed in vitro and in vivo antimicrobial efficiency and protected mice against two kinds of bacterial infections, indicating that Ply30 may be an effective therapeutic against streptococci.


Assuntos
Antibacterianos/administração & dosagem , Endopeptidases/administração & dosagem , Prófagos/enzimologia , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus equi/efeitos dos fármacos , Streptococcus suis/efeitos dos fármacos , Estruturas Animais/microbiologia , Animais , Antibacterianos/isolamento & purificação , Antibacterianos/metabolismo , Bacteriólise , Sangue/microbiologia , Contagem de Colônia Microbiana , Modelos Animais de Doenças , Endopeptidases/genética , Endopeptidases/isolamento & purificação , Endopeptidases/metabolismo , Estabilidade Enzimática , Concentração de Íons de Hidrogênio , Camundongos , Testes de Sensibilidade Microbiana , Viabilidade Microbiana/efeitos dos fármacos , Prófagos/genética , Streptococcus equi/fisiologia , Streptococcus suis/fisiologia , Análise de Sobrevida , Resultado do Tratamento
4.
Eur J Pharm Biopharm ; 165: 174-184, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34015471

RESUMO

The development of Fe-coordination polymer-based nanoparticles, with safe and high anti-tumor effects, for the treatment of tumor is facing challenges such as limited resources and poor targeting. In this study, we prepared Fe-polyhydroxy coordination polymer nanoparticles (TA-Fe@MNPs), based on tartaric acid (TA)-Fe(III) coordination polymer as the new photothermal agent, mannose (M) as the target, and bovine serum albumin (BSA) and polyethyleneimine (PEI) as the carrier materials, and investigated them for targeting the multifunctional therapy of tumors. The TA-Fe@MNPs synthesized via a simple coordination of Fe3+ with TA, bovine serum albumin, and polyethyleneimine under ambient conditions exhibited an appropriate size (~125 nm), electrically neutral surfaces, good biocompatibility, and low normal cell toxicity. The TA-Fe@MNPs are the first to exhibit a remarkable photothermal performance. They also showed a pH-sensitive Fenton-like response that was further enhanced via glutathione response. Interestingly, after a single injection, the TA-Fe@MNPs could be retained at the tumor site for 36 h with an effective photothermal dose, which was attributed to the reduced protein adsorption and slow elimination in tumor cells with the aid of M modification and carrier materials, while that for the TA-Fe@NPs did so for only 2 h. Tumor ablation was demonstrated by in vivo photothermal and chemokinetic therapy using TA-Fe@MNPs, and their safety was evident from the weight changes and blood parameters. These results indicated that the TA-Fe@MNPs, as new photothermal and CDT agents, have the potential to be used in clinical tumor therapy nanoplatforms.


Assuntos
Complexos de Coordenação/administração & dosagem , Portadores de Fármacos/química , Neoplasias/tratamento farmacológico , Fármacos Fotossensibilizantes/administração & dosagem , Animais , Linhagem Celular Tumoral , Complexos de Coordenação/química , Complexos de Coordenação/farmacocinética , Modelos Animais de Doenças , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Compostos Férricos/química , Humanos , Concentração de Íons de Hidrogênio , Masculino , Camundongos , Nanopartículas/química , Neoplasias/patologia , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/química , Fármacos Fotossensibilizantes/farmacocinética , Terapia Fototérmica/métodos , Polietilenoimina/química , Ratos , Soroalbumina Bovina/química , Tartaratos/química , Nanomedicina Teranóstica/métodos , Distribuição Tecidual
5.
PLoS One ; 9(11): e112048, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25397580

RESUMO

Avian pathogenic E. coli and human extraintestinal pathogenic E. coli serotypes O1, O2 and O18 strains isolated from different hosts are generally located in phylogroup B2 and ST complex 95, and they share similar genetic characteristics and pathogenicity, with no or minimal host specificity. They are popular objects for the study of ExPEC genetic characteristics and pathogenesis in recent years. Here, we investigated the evolution and genetic blueprint of APEC pathotype by performing phylogenetic and comparative genome analysis of avian pathogenic E. coli strain IMT5155 (O2:K1:H5; ST complex 95, ST140) with other E. coli pathotypes. Phylogeny analyses indicated that IMT5155 has closest evolutionary relationship with APEC O1, IHE3034, and UTI89. Comparative genomic analysis showed that IMT5155 and APEC O1 shared significant genetic overlap/similarities with human ExPEC dominant O18:K1 strains (IHE3034 and UTI89). Furthermore, the unique PAI I5155 (GI-12) was identified and found to be conserved in APEC O2 serotype isolates. GI-7 and GI-16 encoding two typical T6SSs in IMT5155 might be useful markers for the identification of ExPEC dominant serotypes (O1, O2, and O18) strains. IMT5155 contained a ColV plasmid p1ColV5155, which defined the APEC pathotype. The distribution analysis of 10 sequenced ExPEC pan-genome virulence factors among 47 sequenced E. coli strains provided meaningful information for B2 APEC/ExPEC-specific virulence factors, including several adhesins, invasins, toxins, iron acquisition systems, and so on. The pathogenicity tests of IMT5155 and other APEC O1:K1 and O2:K1 serotypes strains (isolated in China) through four animal models showed that they were highly virulent for avian colisepticemia and able to cause septicemia and meningitis in neonatal rats, suggesting zoonotic potential of these APEC O1:K1 and O2:K1 isolates.


Assuntos
Aves/microbiologia , Escherichia coli/genética , Escherichia coli/patogenicidade , Genoma Bacteriano/genética , Genômica/métodos , Filogenia , Animais , Animais Recém-Nascidos , Embrião de Galinha , Ilhas de CpG/genética , Modelos Animais de Doenças , Escherichia coli/classificação , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/genética , Infecções por Escherichia coli/microbiologia , Genes Bacterianos , Humanos , Camundongos , Dados de Sequência Molecular , Fases de Leitura Aberta/genética , Plasmídeos/metabolismo , Ratos , Análise de Sequência de DNA , Sorotipagem , Virulência/genética
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa